Palvella Therapeutics Inc (PVLA)
28.10 x 1 29.99 x 2
Post-market by (Cboe BZX)
28.10 +0.34 (+1.22%) 03/28/25 [NASDAQ]
28.10 x 1 29.99 x 2
Post-market 28.10 unch (unch) 16:00 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 74,867 | 37,878 | 29,356 | 29,349 | 18,474 |
Marketable Securities | 53,240 | 34,751 | N/A | N/A | N/A |
Receivables | 2,701 | 15,546 | 57 | N/A | N/A |
TOTAL | $135,382 | $89,790 | $32,673 | $31,661 | $19,805 |
Non-Current Assets | |||||
PPE Net | 5,049 | 4,034 | 2,264 | 2,163 | 2,052 |
Investments And Advances | 0 | 9,922 | 0 | 0 | 0 |
Other Non-Current Assets | 910 | 130 | 126 | 127 | 0 |
TOTAL | $5,959 | $14,086 | $2,390 | $2,290 | $2,052 |
Total Assets | $141,341 | $103,876 | $35,063 | $33,950 | $21,858 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | N/A | N/A | N/A | 1,271 |
Accounts payable and accrued liabilities | 3,350 | 2,452 | 2,386 | 1,059 | 1,260 |
Accrued Expenses | 9,114 | 6,170 | N/A | 1,739 | 987 |
Other current liabilities | N/A | N/A | 3,719 | N/A | N/A |
TOTAL | $48,076 | $45,775 | $8,380 | $2,798 | $3,517 |
Non-Current Liabilities | |||||
Deferred Revenues | 35,612 | 37,153 | 2,275 | N/A | N/A |
aiOther Non-Current Liabilities | 27 | 37 | 47 | 24 | 334 |
TOTAL | $53,330 | $46,579 | $1,456 | $24 | $334 |
Total Liabilities | $101,406 | $92,354 | $9,836 | $2,822 | $3,851 |
Shareholders' Equity | |||||
Shares Outstanding, K | 614 | 673 | 538 | 498 | N/A |
Common Shares | 54 | 45 | 43 | 40 | 29 |
Retained earnings | -147,066 | -120,312 | -102,665 | -79,866 | -65,807 |
Other shareholders' equity | -2,982 | -4,695 | -1,501 | -1,273 | -843 |
TOTAL | $39,935 | $11,522 | $25,227 | $31,128 | $18,006 |
Total Liabilities And Equity | $141,341 | $103,876 | $35,063 | $33,950 | $21,858 |